Last edition
News about
HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care
HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.
FDA Grants Orphan Drug Designation to LP-284 of Lantern Pharma
The designation marks the third FDA orphan status for LP-284 and the sixth across Lantern Pharma’s AI-driven oncology pipeline, strengthening the programme’s development momentum in soft tissue sarcomas, a rare cancer segment with significant unmet need and a growing global market.
Abbott Secures CE Mark for TactiFlex Duo Ablation Catheter to Treat Atrial Fibrillation in Europe
Abbott has received CE Mark approval for its TactiFlex Duo Ablation Catheter, enabling dual-energy AFib treatment in Europe and marking successful first commercial procedures across the EU.
Worldwide Clinical Trials to Acquire Catalyst Clinical Research
Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.
GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.
China's NMPA Accepts Akeso's Gumukimab sNDa for Ankylosing Spondylitis
China’s NMPA gives approval to Akeso’s gumokimab for the treatment of active ankylosing spondylitis, supported by Phase III data showing significant symptom relief and functional improvement.
Paracetamol Safe in Pregnancy, Confirms MHRA After Major Lancet Review Finds No Autism or ADHD Risk
The UK medicines regulator MHRA reaffirmed paracetamol as safe during pregnancy after a major Lancet review found no link to autism, ADHD or intellectual disability in children.
Onyx Scientific Strengthens Solid Form Screening Platform Following 25-Year Milestone
Onyx Scientific, the contract development and manufacturing organisation (CDMO) division of Ipca Laboratories, has announced plans to expand its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.
PharmaCloud Bridges Innovation and Compliance in Pharma Manufacturing Operations
Pharma manufacturing continues to grapple with a long-standing challenge: balancing innovation with strict regulatory compliance. While AI-driven technologies have the potential to significantly enhance operator capability and execution consistency, their adoption on the shop floor is often constrained by regulatory and validation requirements.
JB Chemicals Delivers Strong Q3 FY26 Results with Double-Digit Growth
JB Chemicals and Pharmaceuticals Ltd (JB Pharma) reported a strong financial performance for the third quarter of FY26, with consolidated revenue rising to INR 1,065 crore, an increase of around 11 percent compared to the same quarter last year.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy